These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 31653035
1. Quercetin Synergistically Inhibit EBV-Associated Gastric Carcinoma with Ganoderma lucidum Extracts. Huh S, Lee S, Choi SJ, Wu Z, Cho JH, Kim L, Shin YS, Kang BW, Kim JG, Liu K, Cho H, Kang H. Molecules; 2019 Oct 24; 24(21):. PubMed ID: 31653035 [Abstract] [Full Text] [Related]
2. Adenosine Induces EBV Lytic Reactivation through ADORA1 in EBV-Associated Gastric Carcinoma. Choi SJ, Ryu E, Lee S, Huh S, Shin YS, Kang BW, Kim JG, Cho H, Kang H. Int J Mol Sci; 2019 Mar 14; 20(6):. PubMed ID: 30875759 [Abstract] [Full Text] [Related]
3. Quercetin-induced apoptosis prevents EBV infection. Lee M, Son M, Ryu E, Shin YS, Kim JG, Kang BW, Cho H, Kang H. Oncotarget; 2015 May 20; 6(14):12603-24. PubMed ID: 26059439 [Abstract] [Full Text] [Related]
4. Suppression of proliferation and oxidative stress by extracts of Ganoderma lucidum in the ovarian cancer cell line OVCAR-3. Hsieh TC, Wu JM. Int J Mol Med; 2011 Dec 20; 28(6):1065-9. PubMed ID: 21887458 [Abstract] [Full Text] [Related]
5. Inhibitory effects of ganoderma lucidum on tumorigenesis and metastasis of human hepatoma cells in cells and animal models. Weng CJ, Chau CF, Yen GC, Liao JW, Chen DH, Chen KD. J Agric Food Chem; 2009 Jun 10; 57(11):5049-57. PubMed ID: 19422227 [Abstract] [Full Text] [Related]
6. Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activation. Lee HG, Kim H, Kim EJ, Park PG, Dong SM, Choi TH, Kim H, Chong CR, Liu JO, Chen J, Ambinder RF, Hayward SD, Park JH, Lee JM. Oncotarget; 2015 Oct 13; 6(31):31018-29. PubMed ID: 26427042 [Abstract] [Full Text] [Related]
7. Ganoderma lucidum extract inhibits proliferation of SW 480 human colorectal cancer cells. Xie JT, Wang CZ, Wicks S, Yin JJ, Kong J, Li J, Li YC, Yuan CS. Exp Oncol; 2006 Mar 13; 28(1):25-9. PubMed ID: 16614703 [Abstract] [Full Text] [Related]
8. Triterpenes from Ganoderma lucidum inhibit hepatocellular carcinoma by regulating enhancer-associated lncRNA in vivo. Zhao R, Zhang C, Tang C, Wu X, Hu S, Luo Q, Jia N, Fan L, Wang Y, Jiang W, Chen Q. J Ethnopharmacol; 2025 Jan 10; 336():118706. PubMed ID: 39186989 [Abstract] [Full Text] [Related]
9. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression. Zheng X, Wang J, Wei L, Peng Q, Gao Y, Fu Y, Lu Y, Qin Z, Zhang X, Lu J, Ou C, Li Z, Zhang X, Liu P, Xiong W, Li G, Yan Q, Ma J. J Virol; 2018 Dec 01; 92(23):. PubMed ID: 30209170 [Abstract] [Full Text] [Related]
10. Anti-cancer Effects of a Neutral Triterpene Fraction from Ganoderma lucidum and its Active Constituents on SW620 Human Colorectal Cancer Cells. Li P, Liu L, Huang S, Zhang Y, Xu J, Zhang Z. Anticancer Agents Med Chem; 2020 Dec 01; 20(2):237-244. PubMed ID: 31749435 [Abstract] [Full Text] [Related]
11. Network pharmacology analysis of the anti-cancer pharmacological mechanisms of Ganoderma lucidum extract with experimental support using Hepa1-6-bearing C57 BL/6 mice. Zhao RL, He YM. J Ethnopharmacol; 2018 Jan 10; 210():287-295. PubMed ID: 28882624 [Abstract] [Full Text] [Related]
12. EBV as a high infection risk factor promotes RASSF10 methylation and induces cell proliferation in EBV-associated gastric cancer. Gao Y, Fu Y, Wang J, Zheng X, Zhou J, Ma J. Biochem Biophys Res Commun; 2021 Apr 02; 547():1-8. PubMed ID: 33588233 [Abstract] [Full Text] [Related]
13. The mushroom Ganoderma lucidum suppresses breast-to-lung cancer metastasis through the inhibition of pro-invasive genes. Loganathan J, Jiang J, Smith A, Jedinak A, Thyagarajan-Sahu A, Sandusky GE, Nakshatri H, Sliva D. Int J Oncol; 2014 Jun 02; 44(6):2009-15. PubMed ID: 24718855 [Abstract] [Full Text] [Related]
14. A supercritical-CO2 extract of Ganoderma lucidum spores inhibits cholangiocarcinoma cell migration by reversing the epithelial-mesenchymal transition. Li L, Guo HJ, Zhu LY, Zheng L, Liu X. Phytomedicine; 2016 May 15; 23(5):491-7. PubMed ID: 27064008 [Abstract] [Full Text] [Related]
15. Update on Epstein-Barr virus and gastric cancer (review). Shinozaki-Ushiku A, Kunita A, Fukayama M. Int J Oncol; 2015 Apr 15; 46(4):1421-34. PubMed ID: 25633561 [Abstract] [Full Text] [Related]
16. Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir. Hui KF, Cheung AK, Choi CK, Yeung PL, Middeldorp JM, Lung ML, Tsao SW, Chiang AK. Int J Cancer; 2016 Jan 01; 138(1):125-36. PubMed ID: 26205347 [Abstract] [Full Text] [Related]
17. [Significance of the expression of P53 protein and P21WAF1 protein in the gastric carcinoma tissues associated with Epstein-Barr virus (EBV) infections]. Qian J, Li DQ, Zhong F, Li ZX, Lu LC. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar 01; 20(1):1-3. PubMed ID: 16642206 [Abstract] [Full Text] [Related]
18. Gastritis-Infection-Cancer Sequence of Epstein-Barr Virus-Associated Gastric Cancer. Fukayama M, Kunita A, Kaneda A. Adv Exp Med Biol; 2018 Mar 01; 1045():437-457. PubMed ID: 29896679 [Abstract] [Full Text] [Related]
19. A Screen for Epstein-Barr Virus Proteins That Inhibit the DNA Damage Response Reveals a Novel Histone Binding Protein. Ho TH, Sitz J, Shen Q, Leblanc-Lacroix A, Campos EI, Borozan I, Marcon E, Greenblatt J, Fradet-Turcotte A, Jin DY, Frappier L. J Virol; 2018 Jul 15; 92(14):. PubMed ID: 29743367 [Abstract] [Full Text] [Related]